Related Experiment Videos
[Recent advance in inhaled corticosteroid therapy]
Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 26, 2001
Summary
Early intervention with inhaled corticosteroids is key for managing bronchial asthma, preventing irreversible airflow limitation. This comprehensive approach includes diagnosis, intensive therapy, environmental changes, and patient education.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Pharmacology
Context:
- Inhaled corticosteroid (ICS) therapy has advanced significantly over the last decade for bronchial asthma.
- International guidelines recognize ICS therapy's crucial role in asthma management.
- Airway remodeling is a primary cause of irreversible airflow limitation in chronic asthma.
Purpose:
- To introduce early intervention as a novel therapeutic strategy for bronchial asthma.
- To highlight the comprehensive nature of early intervention, including diagnosis, intensive ICS therapy, environmental control, and patient education.
- To discuss the add-on effects of long-acting beta-2 agonists, theophylline, and leukotriene receptor antagonists.
Summary:
- Early intervention, incorporating intensive inhaled corticosteroid therapy, aims to prevent airway remodeling in bronchial asthma.
- This strategy combines early diagnosis, environmental modifications, and patient education for improved outcomes.
- The study also reviews adjunctive therapies such as long-acting beta-2 agonists, theophylline, and leukotriene receptor antagonists.
Impact:
- Provides a new therapeutic paradigm for preventing chronic and refractory asthma.
- Emphasizes a holistic approach to asthma management beyond symptom control.
- Offers insights into optimizing treatment through combination therapies for better patient prognosis.